Skip to main content
Global Site Support
Follow us
✕
Company
Mission
About IXICO
IXI™ Platform
The Power of Neuroimaging
Customers
Partnerships
Leadership Team
Careers
Business Development Director (US)
Associate Clinical Data Manager
Operations Associate
Recruitment privacy notice
IXI™ Platform
Services
Imaging Biomarkers
Radiological reads
Volumetric MRI
PET & SPECT
Advanced MRI
Trial Management
Data Analytics
Post-Marketing Surveillance
Consultancy
Therapeutic Expertise
Alzheimer's Disease (AD)
Huntington's Disease (HD)
Parkinson's Disease (PD)
Multiple Sclerosis (MS)
Other Rare Neurological Diseases
News & Resources
News
Scientific Publications
Webinars
Downloads
Blog
Video
Investors
Share Price
Governance
AIM Rule 26
Our Board
Oversight
Contacts & Advisers
Investor Resources
Company Documents
Financial Calendar
RNS News
Regulatory Email Alert
Shareholder Info
Investor Presentations
Investor Videos
Contact us
Contact Us
Global Site Support
Submit RFP
\
Investor Resources
\
Company Documents
Company Documents
Company Presentations
20 May 2025 –
INTERIM RESULTS PRESENTATION
04 Dec 2024 –
ANNUAL RESULTS PRESENTATION
05 Dec 2023 -
ANNUAL RESULTS PRESENTATION
07 Dec 2022 -
ANNUAL RESULTS PRESENTATION
Financial Reports
20 May 2025 –
INTERIMS REPORT 2025
20 Dec 2024 –
ANNUAL REPORT 2024
04 Dec 2023 -
ANNUAL REPORT 2023
07 Dec 2022 -
ANNUAL REPORT 2022
Shareholder Documents
20 Dec 2024 –
AGM 2025 - Notice
9 October 2024 -
General Meeting 2024 – Form of Proxy
9 October 2024 -
Shareholder Circular and Notice of General Meeting 2024
9 October 2024 -
IXICO Rules of the EMI Share Option Plan 2024
15 Dec 2023 –
AGM 2024 - Notice
16 Dec 2022 -
AGM 2023 – Notice
Other Documents
25 Jan 2025 -
Articles of Association
23 Sep 2013 -
AIM Admission Document
IXICO Broker Analyst Reports
Analyst Reports Overview
IXICO Broker Analyst Reports
